What to know
- A recording of this webinar is available below. Visit CDC TRAIN to get free continuing education (CE) for this webinar.
- The TRAIN course registration code is ZOHUwebcast
Webinar details
Presentation topics
- A novel presentation of coccidioidomycosis (Valley Fever) in a southern sea otter
- Enhancing One Health outcomes with decision analysis: Case studies across wildlife disease systems
- Outbreak of highly pathogenic avian influenza a (H5N1) among house cats: A case series involving oseltamivir treatment
Presenters
- Heather S. Harris, DVM, MPVM, DACVPM, Associate Veterinarian, The Marine Mammal Center, harrish@tmmc.org
- Jonathan Cook, PhD, Research Biologist, U.S. Geological Survey, Eastern Ecological Science Center, jcook@usgs.gov
- Kristen K. Coleman, PhD, Assistant Professor, University of Maryland School of Public Health, kkcolema@umd.edu
- Jacob F. Gomez, DVM, CEO/Veterinarian, Cross Street Small Animal VH, Inc., jake@crossstvet.com
Get email updates
Sign up for the ZOHU Call email newsletter below.
Continuing Education (CE)
Visit CDC Train to receive free CE.
- Course Name: WC5035-080526
- Registration code: ZOHUwebcast
- Course available: August 5, 2026 - August 7, 2026
- Course Name: WD5035-080526
- Registration code: n/a
- Course available: August 8, 2026 - August 8, 2029
Objectives
By the end of this webinar, participants will be able to:
- Identify at least one impact the One Health issue has on human, animal, or environmental health.
- Identify at least one One Health approach strategy to help prevent a public health threat.
- Identify at least one One Health approach strategy to help detect a public health threat.
- Identify at least one One Health approach strategy to help respond to, or prepare for, a public health threat.
- List two ways to improve collaborative practice across the public healthcare team.
Disclosures
In compliance with continuing education requirements, all planners and presenters must disclose all financial relationships, in any amount, with ineligible companies over the previous 24 months as well as any use of unlabeled product(s) or products under investigational use.
CDC, our planners, and presenters wish to disclose they have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Content will not include any discussion of the unlabeled use of a product or a product under investigational use.
CDC did not accept commercial or in-kind support for this activity.
This page was last updated on this date. Updates may include minor edits, image changes, or other modifications to page content.
The information on this page was last reviewed by subject matter experts to ensure accuracy.